European Medicines Agency to review Sanofi-Regeneron's Dupixent, Cemiplimab

PARIS (Reuters) - The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news